Advertisements


We are Sorry, This Page doesn't Exist


Can Robust Sales Aid Kirkland"s (KIRK) This Earnings Season?

Kirkland's (KIRK) Q1 results to gain from solid sales, backed by robust merchandise assortments, e-commerce business and constant store additions. However, rising operating expenses are a concern. Kirkland's, Inc K.....»»

Category: topSource: zacksMay 29th, 2018

What"s in Store for Endocyte (ECYT) This Earnings Season?

Endocyte (ECYT) is expected to provide updates on pipeline candidates when it reports first-quarter 2018 results on May 9 after the market closes. Endocyte, Inc. ECYT is.....»»

Category: personnelSource: nytMay 8th, 2018

Is a Beat in Store for Epizyme (EPZM) This Earnings Season?

Is a Beat in Store for Epizyme (EPZM) This Earnings Season?.....»»

Category: dealsSource: nytMay 7th, 2018

Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More

The pharma/biotech industry has witnessed a mixed first-quarter earnings picture so far. Let's see what's in store for some of the smaller players. The first-quarter earnings season has been relatively stro.....»»

Category: personnelSource: nytMay 7th, 2018

What"s in Store for Penumbra (PEN) This Earnings Season?

Penumbra (PEN) deepens its focus on driving innovation, ramping up production and expanding geographies. Penumbra, Inc. PEN is expected to repo.....»»

Category: personnelSource: nytMay 4th, 2018

What"s in Store for Celldex (CLDX) This Earnings Season?

With no approved product in Celldex Therapeutics' (CLDX) portfolio, investor focus is on i.....»»

Category: personnelSource: nytMay 3rd, 2018

What"s in Store for Intrexon (XON) This Earnings Season?

Intrexon Corporation (XON) is expected to report first-quarter 2018 results on May 9, after the market closes, and wil.....»»

Category: worldSource: nytMay 2nd, 2018

What"s in Store for DENTSPLY (XRAY) This Earnings Season?

DENTSPLY's (XRAY) CAD/CAM unit is likely to drive the top line in Q1. Product innovations and strong R&D prospects are also likely to drive growth. .....»»

Category: worldSource: nytMay 2nd, 2018

What"s in Store for Catalyst (CPRX) This Earnings Season?

Catalyst (CPRX) is expected to report first-quarter 2018 results on May 9, after the market clo.....»»

Category: personnelSource: nytMay 2nd, 2018

What"s in Store for Intercept (ICPT) This Earnings Season?

Investors are expected to focus on Ocaliva sales when Intercept (ICPT) reports first-quarter results (expected on May 3). Intercept Pharmaceuticals, Inc. ICPT is expecte.....»»

Category: worldSource: nytApr 30th, 2018

What"s in Store for ImmunoGen (IMGN) This Earnings Season?

Immun.....»»

Category: personnelSource: nytApr 30th, 2018

What"s in Store for Chesapeake (CHK) This Earnings Season?

Higher expected oil equivalent production will likely support Q1 results of Chesapeake Energy (CHK). Chesapeake Energy Corporation .....»»

Category: smallbizSource: nytApr 30th, 2018

AbbVie Delivers Solid Growth in Earnings and Revenue

AbbVie released first quarter of 2018 resultsRelated Stocks: ABBV,.....»»

Category: dealsSource: nytApr 30th, 2018

What"s in Store for PPL Corp (PPL) This Earnings Season?

PPL Corp. (PPL) expects to benefit from higher transmission earnings and higher cash repatri.....»»

Category: smallbizSource: nytApr 30th, 2018

What"s in Store for Unum Group (UNM) This Earnings Season?

Better performances at Unum U.S. and Colonial Life are likely to aid Unum Group's (UNM) first-quarter earnings. Unum Group UNM will repor.....»»

Category: topSource: zacksApr 27th, 2018

AbbVie (ABBV) Q1 Earnings Beat, 2018 View Up, Stock Gains

AbbVie's (ABBV) Q1 earnings top estimates .....»»

Category: smallbizSource: nytApr 26th, 2018

Interpublic (IPG) to Report Q1 Earnings: What"s in Store?

Higher organic growth and positive foreign currency impact are likely to drive Interpublic's (IPG) first-quarter 2018 revenues. Earnings are likely to be hurt by season.....»»

Category: personnelSource: nytApr 25th, 2018

Is a Beat in the Cards for AbbVie (ABBV) in Q1 Earnings?

Impressive sales rise of AbbVie's (ABBV) key drugs, Humira and Imbruvica, might lead the company to an earnings beat .....»»

Category: dealsSource: nytApr 24th, 2018

Is a Beat in Store for Alexion (ALXN) This Earnings Season?

Zacks.....»»

Category: topSource: redinewsApr 24th, 2018

What"s In Store For Biogen This Earnings Season?

Biogen Inc. (NASDAQ: BIIB), a well-known name in the multiple sclerosis market, will report first-quarter 2018 results on Apr 24, before the market opens. Last quarter, the company delivered a negative earnings surprise of 3.31%. B.....»»

Category: earningsSource: benzingaApr 23rd, 2018